Genome Canada is pleased to launch a new funding opportunity – the 2015 Large-Scale Applied Research Project Competition Natural Resources and the Environment: Sector Challenges – Genomic Solutions.
June 11, 2015 – Genome Canada is pleased to launch the 2015 Disruptive Innovation in Genomics (DIG) Competition.
Today, Canada marks the major scientific discovery of DNA’s double helix structure, published in Nature by James Watson and Francis Crick in April 1953. The discovery – arguably one of the most important of the 20th century – answered a fundamental mystery about how living organisms pass genetic instructions from generation to generation, and eventually enabled later researchers to understand the genetic code.
A new research project, funded by Genome British Columbia (Genome BC) and Genome Canada, aims to improve the strategies for monitoring the impact of Mount Polley Mine tailings breach on the ecosystem and to provide recommendations for environmental remediation.
Avian influenza is a contagious viral infection that can affect all species of birds (chickens, turkeys, guinea fowl, pet birds and wild birds). Some avian influenza (AI) strains can also cause illness in humans. From December 2014 to January 2015 there was an outbreak of a highly-pathogenic avian influenza (HPAI) in the Fraser Valley which involved 11 commercial and two non-regulated residential farms, leading to the death or destruction of approximately 240,000 birds.
Genome Canada is pleased to announce a $15.5 million investment in Canada’s new Genomics Innovation Network. The Network is comprised of ten “Nodes,” each receiving core operational funding from Genome Canada, with matching funds from various public and private sector partners.
Genome Canada is delighted to welcome Darlene Arseneau (CPA, CA) as Vice President, Finance and Corporate Services, effective March 2, 2015. Ms. Arseneau has led many local and provincial initiatives in Ontario in support of the Community Care Access Center, Ministry of Health and Long Term Care. Since July 2014, Ms. Arseneau has been Deputy CFO at the Children’s Hospital of Eastern Ontario. Prior to arriving in Ottawa with her family, Ms.
Epimeron Inc. (“Epimeron”), a Calgary-based biotechnology company, today announced that it has licensed certain of its proprietary technologies to a US-based company. The terms of the agreement were not disclosed.
The PED virus kills young piglets at an astonishing rate with a near 100% mortality rate in suckling pigs. A Canadian effort has been launched to understand and stop the disease to protect the young pigs and to aid the pig industry in North America.
Genome Canada is pleased to advise the research community of an upcoming funding opportunity – the 2015 Large-Scale Applied Research Project Competition Natural Resources and the Environment: Sector Challenges – Genomic Solutions. This Competition is anticipated to be formally launched in Spring 2015 with detailed guidelines and application forms available at that time.